367
Laboratoired'ErdocrinAogie, H6pitalNotre-D~~ DSpar&mentdeM&kcine, Uni~siSde&xkr&il, MontSal, Canada. Received: 5/31/71
Ikrnan beard hair follicleswere incubatedin vitro with testostero1-~-7-3~, ar&ostenedione-1,2-3~ ti dehydroepi4J4c. The principalme~litesof testosteronewereardrostenedione, 5a-androstanedione,5a-dihydrotestisteroneard ardrosterone.Theconversionof androstensdioneinti testisteroneand5u+Wqdrotestosteronewasvery limited. Dehydroepiardrost was metabolizedTV 5-androstene-38,17Bdiol, 7a-hydroxy-dehydroepiardrosterone ard androstenedione, kith rates of formationfar excesdingthosereportedfor hunan skin. The siqnificance of thesemetabolictransformations is discussedwith specialreferencetothemechanisnofactionofa&rcgens.
As a resultof nrmerousinvestigations, it has beaxne firmly establishedthat hunan skin is an active site of arxdrogametabolism. TeStOsterone,androstenedione and dehydroepiardrosterone are metabolizedextensivelyby survivingpreparations of this tissue (1,2,3,4,5). The transformationoftestosteroneinti 5a-diJ@rotestosterone (DlTJ?) has beendanonstratedto occur inhuman skin (2,6). This kichisanorepotentaklrogen
than
steroid,
testosterone, is probablytheactive
formof this hormoneina number of axkogen-sensitivetissuessuchas the ventralprostate,seminal
vesicles, preputialglands,epipidymisard
the canb of chicks (7,8,9). For a betterundersizrding of the role of hormonemetabolitesin themechanismof actionof ardrogens,it
is important to study themeta-
kolisnof these hormonesin a numberof targetorgans. It is well tiwn that the growthard distributionof body hair is controlledby androgens. I&ever, theirmetabolismardmodeofaction in the hair folliclerenainsto be elucidated. For our studieswe selectedthe folliclesof the ~WW organ
for testosterone.
beard which are obviouslya target
STEROIDS
368
We
184
have thereforeexaminedthe _invitro metabolismof testosterone
-7-3H,ar&ostenedione-1,2-3H ard dehydroepia&rosterone-4-14C by the isolatedbeardhair folliclesobtainedEm
t&o &althymales andone
hirsutefemalepatient.
Beard hair follicleswere pluck& freshlyfran TV males (ages: 34 a& n years) ax-drrcma~ (age: 32 years)withidiopathic hirsutism. Afterweightmeasurenent,thefolliclesweretransferredintiflasks contai.ningtbelabell&steroidsubstrate. In each flask, 20 follicleswere incubatedin 1.5 ml of Irtn;rbations. Krebs-Ringer-Ptisphate solution,pH 7.3, containing200 ng% glucoseand 50 pg eachof NAD, NADP, NADHard NADPH. The incubations were carried autbyshakingthesamplesinairatmosphereat37Cfor5hcrurs. In thoseexperiments,wheretheeffectof cyprotsroneacetatewasinvestigated, itms added to the flasksin 0.02mlof etharolattheonsetof the incubation(20 pg of cyproteroneacetate/flask). SteroFds, Radioactivesteroidspurcha~franNew~l~NLbclearcOrp., Boston,Mass., werepurifisdbeforeuseb.ypaperchranatographyinthe Bush A system (IIf. Steroidsusedas substrateshad the followingspe58.8 r&X&M; testistecific a tivities: dehydroepiar&osterone-4-14C: 9H: 25 Ci/rrM;4-arrdrostene-3,17-dione-l,2-3H: 48 Ci@% rone-7Peferae steroidswere obtainedcmercially fran Ikapti (Pamat Can, Israel)or SteraloidsInc., Pawling,N.Y. 7cr_hydroxydehydroepiandrosterone-diacetatewas agiftfmthe SteroidPeferenceCollection, MRC,I.otion,-land. lbe followingquantitiesof labelledsteroidswere used for the incubations: dehydroep&&rosterone: 0.3 IrCi,5220.83wflask; testosterone: 1 uCi, 40.0 PM/flask;ardrostenedione:1 UCi, 20.83 @l/flask. Par use as internalstardards,5cr-androstandione-4-14C was synthesized fran 5a-dihydrotestosterone-4-W by oxidationwith Q-03 ard 5-androstene-3b,17B-diol-3H frcm dehydroepiarrlrosterone-7-3H by reduction with scdi.Lan borohydride(10). Isolationard identification of metabolites. After incubation,the volume of the incubationmixturewas broughtto 10 ml with distilledwater and upon additionof 100 Figeach of nonradioactive authentictestisteroneand arxdrostenedione, the ste~XG& were extract& with 2 x 20 ml of methylene chlorideandlx 2Oml benzene. The organicpbaseswerecanbined ard evaporatsdto dryness. Steroidsin thedry residuewere first resolved byaninitialpaper chranatographic step. Theextracts of testosterone arrlarxlrX?stenedione incubateswere run in Push A, tbile tise of the de@droepia&rosterone ir~~W9ons in the Bush Bl system (11). After scan~~c~~~, theradioactivezonescorrespon%_ngto therunningrateofauthenticrefere.ncesteroidswereelutedand identifiedby furtherchrcmatographic separationsinpaperandvarious thinlayerchron-atographic (TLC)systemsand serialcrysiallizationticonstantspecific activityor isotoperatio. V&never applicable,authenticradioactive internalstandardswere used for the identification of tiividual steroids. Thesewereaddedafter the initialpaperchranatcgraphic step. Results
Oct. 1971
STEROIDS
369
weremrrecttrlfcx lossesooxrredduringextraction~ the initialpaperchrcxnatographic stepbasedontherecoveries of au-tic mnradioactive testosteronearrdardrostenedione. 0xntitativemeasurementof radioactivitywasperfomed ina Packard LiquidScintillationSpectr~. The fol.lmingTLC systanswereused: for silica-gel-Gplates:TICla: cyclohexane-ethyl acetate (60:40,v/v)f4l;TIC-GH: ~~of~~~ml (98.25:1.'75, v/v)(2f;for alumjnaplates: TIC-E: n-hexam-ethylacetate-glacial acetic acid-a&. ethanol (20:210:1:10, v/v/v/v>;TLC-F: nhexane-ethylacetate-glacial aceticacid-&s. ethanol (10:210:1:20, v/v/ v/v,(3). Fre-coatedTLC sheetswere us&, obtainedfran Merck A.G., lkmstadt, w. Gexmany. FtEsuLTs
ILncbuations with testoste.rone-7-'H. The follawingmetaboliteswere isolated(Table1): 1.
I-Androstene-3,17-dione. Thissteroidwaselut&ifranthe
initialchrcxnakgmmrun in theBushA system. After theadditionof 42,500DPM of authenticandrostenedione-4-14C ard 8,900 DPM of Eja-dihydrotestisterone-4-14 C, ardrostenedione was separatedin the systemWGE. Theidentityof the steroidwas furtherestablishedbyserialcrystallizationto constantisotoperatio. This caqxnmd was ccxnpletely se2..5a-Ardrostahe-3,17-dione. paratedby the firstpaperchranatographyintheBushA
system. After
the additionof 11,000DPM of authentic5a-ardrostane-3,17~ione-4-14C and ~s~tc~~~~
inTIC-la itwas crystallizedtoconstant
specificactivity. 3. 5a-Dihydrotestistemme.J&sr dionein'lU=a,
separationfmna&rostene-
this steroidwas furtherseparatedfmnakimsterone in
the Bush A systemand identifiedby serialcrystallization(Table5). 4. Pndrosteronewasseparatedfrandihydrotestisteroneinthe 14C labelledandrosterone was available,the BushAsysten. Since m losseswere correctedas for dihydrotestosterone. Lfter elutionfran the paper, 4Omgof
authenticsubstancewereaddedand the steroidwas crys-
tallizedto constantspecificactivity. SItall guantitiesof radioactivity refrained with 5a-a.xIrostane-3f3, 17~-dioland 5a-ardrostam-3a,17f3-diol during serialcrystallization. These steroidsweremtregarded as identified, but their presencewas indicatedas furthermetabolitesof 5a-dihydrotestosterone in the hair
f&4
STEROIDS
370
CcmpaundIsolated Ardrostenedione
M-l-CA
M-l
M-2
H.F.
76.31l6.70) 59.8Ol5.27) 198.0(17.39) 81(5.33)
%-findrostanedione
8.3110.73)
6.54(0.57)
25.28(2.22)
5.5(0.36)
Androstemne
0.59(0.05)
0.34(0.03)
0.54(0.05)
1.70fO.U.)
5a-Dih#rotestosterone 4.21cO.37)
2.67tO.23)
8.88tO.78)
1.78(0.12)
Quantitiesofradianetabolites areexpressedas@%&s
fome.i/loomg tissue/hr.
IQ_nrbers in bracketsrepresentpercentageof substrateconverted/incubation flask. M: male H.F,: hirsutef&e CA: cyproteroneacetateadded, 20 ug/flask.
mBm2 m-4-14 MEIlAE0LITFSOFDETJYDKEE'IANDROS
canplzx3
Isolated
M-l
7a-HydroxpDHA
1,654U.U) 5-Andmxten~3B,17B-diol2,500(1.68)
Ardrostenedione
196(0.13)
C~WITHBEZU?DHAIRlX&LI~S
M-l-CA
M-2
H.F.
670(0.47) 1,450(0.97)
575tO.38)
1,340(0.90) 2,350(1.58)
1,060(0.53)
160(0.10)
267cO.18)
Quantitiesof radianetabolites are expressedas poles form&/100 q
192fO.13) tissue/hr.
i&mh.rsin bracketsrepresentpercentageof substrateconvert~/incubation flask. M: male H.F.: hirsute
female
CA: cyproteroneacetateadded,20 ug/flask.
Oct. 1971
371
STEROIDS
MlmAEfxITEScF4-m
RXXENE-3,17-DIoNE-1,2-3H I.mJBmmwITHm HAIRFo.TLI~
ccmpaurd
Isolated
M-2
H.F.
!lkStiSt@XlIE
12.45(2.09)
0.60(0.076)
5a-Adrostandione
13.07(2.20)
4.80(0.60)
5a-Dihykotestmtne
0.50(0.08)
traces
An3_roslzercme
0.48(0.08)
traces
Leged as in Y&de 1.
mBLE4 ISCXATIQNAND IDENCIE'I~IONW
7a-HYDROXY-DBAFRa'dIIJ=uBATION@l-2)
OF DEBYD~El'IAN>ROSTEW3NE_4_14C WITH =
Chr~tographic Bush Bl
TLC-F
systen
Derivative
Specific Activity
Freesteroid ,I
125 ug carrier added
TLC-la
3,7-diacetate
'IX-E
Freeste?zoid II
Bush B5
HAIR FOLLICLES
62 DpM/ug 46 47
" II
" II
48
"
"
STEROIDS
372
18:4
follicles. larger quantities of tissuearenecessary
inorder toobtain
eraoughradioactivity for their ccmplete identification, Incubations with 4-ar&ostene-3,17-dione-l,2-3H. 'IWOsuch incubations me
carried out, one with the beard follicles
of a male (M-2) anclthe other with those of the hirsute female patient. Testosterone, k-dihydrotestosterone and S-ardrostenedione were isolated fran these incubations. The methods me internalstardardswereused, Incubations
as outlined; carbon-14-labelled
followed by serial crystallization (Table 3).
with dehydroepiandrosterone-414C (Table 2). 1 5-Pnkostene-36,17B_diol was isolated by the initial paA.
per chrcmatography in the Bush Bl system. After adding authentic 5-androstene-3fi,17f3-diol-3H the steroid was identified as outlined in Table 5. 2. 7a-Hydroxy-dehyzdroepiarrdrosterone. After separation in Bush Bl, 125 pg of authentic nonradioactive carrier was added to the samples and the can@
was identified along the lines shown in Table 4.
3. 4->&rostene-3,17-dione. Pfter
elution fran the initial
chrcmatcgram in Bl and addition of 72,000 DFM of authentic ardrostenedione-3H themixturewas
run in the BushA
system. The region corresponding
to ardrostenedionewas eluted ard purified in TLC-GH, followed by crystallization to constant isotope ratio (Table 5). Small quantities of radioactivity were found to remain with 5a-androstanedione and androsterone during serial crystallization. Lowever, these caqzounds were not regarded as identified. I;0radioactivity was associated with testosterone or 5c(-dihydrotestosterone after several steps of crystallization. In addition to the above described steroids, two further derivatives of dehydroepiandrosterone,with minor radioactivity were localized by scanning on the initial Bl strips. These steroids were not identified, but according to their polarity, they were oxygenated derivatives of DHA. Tables 1, 2 ard 3 show the quantities of metabolites formed fran the three substrates. Tables 4 and 5 illustrate examples of the identification sequence of various steroids.
373
STEROIDS
Oct. 1972
WIT
Steroid Identified
Al&OS~&iO~
TestoSteI-0~
Substrate
D-IA
DB
M-2
M-l
M-2
8I900 DPM Dwr-b%
72,100DFM ardr stsH enedione-1,2-
Ixubation Inwstardard
Ardrosteraediol
Chrunatxqraphic Sysm
BWhA
Bush
TLC-GH
BushA
BUshA
TLC-GH
Serialcxystalli-
R:
B1
52,00013pMandxostenediol-3H Bush Bl TLC-E !t!LC-la(diacetate)
3H#/14c
R:3H,?4&
Zati0Z.l
CR
solvent:
ML
CR
ML
CR
ML
1. methawltwater
1.53
-
80.4
-
5.20
4.30
2. acetone:xwthawl:
1.52
3.20
82.3
43.0
5.40
4.90
1.51
2.03
84.4
69.0
5.51
5.20
water
3. cyclohexane:ethgl acetate
4. hleGUK?:benZelle
1.49
1.53
82.5
8165
5.53
5.49
5. acetxxwwater
1.50
1.45
81.0
82.3
5.53
5.50
6. metharwl:water
1.45
1.45
81.0
82.0
7. cyclohexarwethyl
1.51
1.51
acetate
M-male;
E-t-l-&i0;
CR-crystals;
ML-xwthfxliqwr;
DBA-deh@YWpiandxosteIone
18:4
STEROIDS
374
DISCtJSSION The rate of transformation of tes&Xkerone into Su-dihydrotestostegenerally less
roneby ~eh~~~~fo~icles~s
tknthatfound
with human skin (Table6). The values publishedby Wilson ti Walker (12) hcrwwerseem to be exceedinglyhigh, which might be due tc contamination by androsterone.On the other hand, the metabolicactivityof pubic skin slices (13)was less than that of the hair follicles. In thebeard hair folliclesthe major productswere androstenedione ard anlrostaneione followedby 5cr-dihydrotestost. probablylargelydement
The rate of DHT formationis roost
on the type of tissueinvolved. Northakt
etal. (15)have shown avery
intensiveDHT formationby hLnnanpubichair
follicles,while accordinglo anotherreport the scalp hair follicles formedvery littleDHT (16). Similarly,human skin samples,t&en frcan perinealareas exhibit&dexcessivelyhigh rates of this conversioncanpared to the activityof skin samplesoriginatingfran variousother sites (12). The oxidationof testosteroneto ar&osten&ione is an inactivation step when the steroidloses its 17@-hydroxyl-groplp, which is responsiblefor ankogenic activity. This transformationisweaklyreversible in the hair folliclesas shown by the i.ncu&tionswith androstenedione and might serve as a regulativeprocess to set the levelsof testosteroneavailablefor Sa-reduction.Tissueswhich are not arrdrogendeperrkntdo rotformDHT - testosteroneis metabolizedexclusivelytr, androstenedione and 5a-akkrostanedione in canine urinarybladders (17) ard in the submaxillarygland of the dog (18). Dehydroepiardrosteronewas intensivelymetakolizedbythebeard follicles. One of the three major metakolites,5-ard.rostene-3B,178-diol is amorepotenta&rogentbanDHA
(19)and itcanbeconvertedinto
testosteronedirectlybythe actionof 3Pol-dehydrogenase-isaseas shown w Rosner ax-dMacane with hunan testiculartissue (20). The rates of formationof 5-ar&ostene-3B,17B-diol and 7ol-hydroxy-DHA were found toben~chhigher thanthoseby humanskin (Table6). Thedifference for anlrostenediol is SO-100fold and for 7a-hydroq-DHAabout tenfold in favourof the follicles. Therefore,thesetwocanpoun% appear IXIbe even zore characteristic of the beard hair folliclesthan DHT since the
STEROIDS
Oct. 1971
375
Fkard follicles Product
substrate
5a-DHT
!&stas+zenme
TkStYXterone
Androsten&ione
mle
skinarea
fenale I various prepuce scrotun
4.2 8.9
1.8
12.5
0.60
46 -_ 1-2
382 2
534 ___
(12) ( 6) (13)
454
--
--
( 4)
--
--
(14) ( 5) ( 3)
--
--
( 5) ( 3)
-c
--
(10) ( 3) (14)
l 5-Androstene3&17wiol
DHA
2,500 2,350
1,060
10-105 20 90
7wCH-DHA
DHA
1,654 1,450
575
140 80
196 267
192
ArdrosMoneDm
Metabolicactivities areexpressedas
Wles
wference
20 50 80-1,500
of steroid fomed/lOOmg
tissue/lx
STEROIDS
376
synthesisof the latter is canparativelyless praninentin this tissue (Table6). The
transformation of dehydroepiardrosterone into ardrostenedione
occurredat rates within the range describedfor hunan skin (Table6). metabolismof this steroidtowardsandrosteroneobviouslytakes
Further
place,but,with decreasedintensity. This pathwaymight have significance in pathologicalstatesas, for example,hirsutism. The intensiveformation of ardrosteroneby the beard folliclesof the hirsutefemaleunderlines this possibility(Table1). Thepresenceof theactiveanIAar&ogencyproterone acetateinthe incubationsresultedin sune inhibitionof the conversionof testosterone to all its metaboliteswith no selectiveeffecton 5c&ihydrotestosterone formation. This is ccnsistentwiththeobservationsthatcyproterone ard cyproteroneacetateantagonizethe actionof testisteroneby ccmpeting for intracellular birxding proteinsof male accessoryreproductive glards (22,23). Theeffectof this antiandrogenwas~reprorrouncedon the 7o-hydroxylation of DHA and formationof 5-ardrostene-38,17B_diol. The metabolismof testosterone by the beard folliclesof the hirsute fenaledifferedquantitatively frcm that by the male follicles. The formation of DEE was relativelyless intensivewith an androstenedione:DHT ratio of 45.5, in contrastto 22.3 and 18.1 in the male cases. Synthesis of androsteronefrcxntestosterone was more intensive,while transformation of ardrostensdione into testosterone was 20 times less efficientthan in the male follicles. Similarshiftsofmet&.olic intensitiescanbeobserved in the utilizationof DHA, where with less formationof 7a-hydroxy-DHA ard 5-androstene-3@,17B-diol the conversioninto arxlrostenedione was equivalentin intensityto one of the male values (Table2). In conclusion,the presentwork shows that the hair folliclesof the hm
beard intensivelymetabolizeax&ogens. Scme of thesemetabo-
lites,such as 5cl-dihydrotestosterone ard 5-ar&ostene-3B,17B-diol, are biologicallyn-ore~tentardrogensthantheparentaxqou.rx%. These fir& ings favour thehpthesis
thatthemetabolites formed in the targetorgan
might serve as the active forms of circulatingardrogens(7,24). ibwever, in order to establisha causal relationship betweenhair grcwthard the metabolitesformed in the hair follicles,the effect of these steroids
STEROIDS
Oct. 1971
377
I
*..I:
.*. J % '0
%
*
STEROIDS
378
has to be examined
18~4
on protein synthesis ard keratinization in this tissue.
Studiesof this Mturearecurrentlyurrlerkayinourlaboratory.
This investigationwas sqqxxted byagrantfran
theM&icalResearch
Ccnmdl of the Province of Quebec (no. 2541). The excellent tedmica assistance of Miss Judith Sylvester is gratefully ackncwl&g&.
1.
Rmgone, E.L.: Steroids, 7_,489, 1966.
2.
Ganez, E.C. and Hsia, S.L.: Biochenistry,2, 24, 1968.
3.
Far&in, I., Fazekas, A.G., K&ai, K., !lbth,I. a~@ Julesz, M.: Eur. J. Steroids, 2_,223, 1967.
4.
Faredin, I., Tbth, I., Fazekas, A.G., Kdcai, K. ard Julesz, M.: Int. J. of Dermtology, 2, 147, 1970.
5.
Far&in, I., Fazekas, A.G., !lbth,I., Kdcai, K. ad J. Invest. Dermatology, 52, 357, 1969.
6.
Voigt, W., Fernardez, E.P. ard Hsia, S.L.: J. E%iol.Chem., I245 5594, 1970.
7.
Bruchovsky, N. ad
8.
Gloyna, R.E. and Wilson, J.D.:
9.
Anderson, K.M. and Liao, S.: Nature, 219, 277, 1968.
Wilson, J.D.: J. Biol. Chm.,
Julesz, M.:
243, 2012, 1968.
J. Clin. Erdocrinol., 2,
970, 1969.
10.
Faredin, I., Kokai, K., Tbth, I., Fazekas, A.G. ard Julesz, M.: Acta Med. Acad. Sci., Hung., 27_,95, 1970.
11.
Bush, I.E.: Biochm. J., 50. 370, 1952. Wilson, J.D. and Walker, J.D.: J. Clin. Invest., 48, 371, 1969. Jenkins, J.S. and Ash, S.: J. Erdocr., 2, 515, 1971.
12. 13. 14.
Chakrabxty, J., !&cmson, J., MacSween, M.P., Muir, A.V., Calman, K.C., Grant, J.K. ard Milne, J.A.: Br. J. Derm., 83, 477, 1970.
15.
Northcott, R-C., Iskuu3, 2, 422, 1969.
16.
Sansone-Bazzano,G., Reisner, R.M., Bazzam, G.: 169, 1971. (Abstr.)
17.
bbrfin, R.F., i?liapaulios,M.E,.,Chambeslain, Esxk3cxinology, 87_,394, 1970.
18.
Weiner, A.L., Ofner, P. ad 1970.
19.
Dxfman, R.I. an3 Dorfman, 1962.
D.P. and Liddle, G.W.:
J. Clin. Endocr., Clin. Res., -' 19
J. and Ofner, P.:
Sweeney, E.A.: Enckxrinology,
87, 406, -
A.S.: Acta Endccrinol., Suppl., 74,
3,
Oct. 1971
STEROIDS
379
20. Rosner, J.M. and Macome,J.C.: Steroids, 15, 181,
1970.
21. Pochi, P.E. and Strauss, J.S.: J. Invest. Derm., 52, 32, 189. 22.
Stern, J.M. and Eisenfeld, A.J.:
Science, l66, 233, 1(&I.
23.
Fang, S. and Liao, S.: Mol. Pharmacol., 5, 420, 1969.
24. Baulieu, E.E.: Rev. Europ. Etudes Clin. et Biol., 15, 723, 1970.
25. Systematic nomenclature: Androstenedione: bandrostene-3,17-dione 5a-Androstandione: 5c+androstane-3,17-dione ?a-Dihydrotestosterone(DHT): 17P-hydroxy-5a,-androstan-j-one Androsterone: jcz-hydroxy-f&z-androstan-17-one Androstenediol: 5-androstene-$,17j3-diol Dehydroepiandrosterone(DHA): 3p-hydroxy-5-androsten-17-one 7a-Hydroxydehydroepiandrosterone:3/3,17a-dihydroxy-5androsten-17-one Testosterone: 17fi-hydroxy-4-androsten-j-one Cyproterone acetate: 1,2a-methylene-6-chloro-17-hydroxy-k,6pregnadiene-3,20-dione-17'-acetate